Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin continuation versus placebo withdrawal in bronchiectasis
ISRCTN59922389Phase 4Recruiting
- Sponsor
- Newcastle Hospitals NHS Foundation Trust
- Start
- Jul 2025
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial in bronchiectasis comparing Continuation of long-term azithromycin with Matched placebo (2 arms). Primary endpoint: Time to first bronchiectasis exacerbation. Started Jul 2025; status: recruiting.
02
Drugs
azithromycin
03
Conditions
bronchiectasis
Beyond the preview
Go deeper on ISRCTN59922389.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN59922389.